National Academies Press: OpenBook
« Previous: 5 Closing Remarks
Suggested Citation:"References." Institute of Medicine. 2010. The Value of Genetic and Genomic Technologies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12947.
×

References

Anderson, J. L., B. D. Horne, S. M. Stevens, A. S. Grov, S. Barton, Z. P. Nicholas, S. F. Kahn, H. T. May, K. M. Samuelson, J. B. Muhlestein, and J. F. Carlquist. 2007. Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anti-coagulation. Circulation 116(22):2563–2570.

Ansell, J., J. Hirsh, E. Hylek, A. Jacobson, M. Crowther, and G. Palareti. 2008. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(6 Suppl):160S–198S.

Caraco, Y. S., S. Blotnic, and M. Muszkat. 2008. CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: A prospective randomized controlled study. Clin Pharmacol Ther 83(3):460–470.

Eckman, M. H., J. Rosand, S. M. Greenberg, and B. F. Gage. 2009. Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation. Ann Intern Med 150(2):73–83.

EGAPP (Evaluation of Genomic Applications in Practice and Prevention) Working Group. 2009. Recommendations from the EGAPP Working Group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med 11(1):35–41.

Flockhart, D. A., D. O’Kane, M. S. Williams, and M. S. Watson. 2008. Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin. Genet Med 10(2):139–150.

Hampel, H., W. L. Frankel, E. Martin, M. Arnold, K. Khanduja, P. Kuebler, M. Clendenning, K. Sotamaa, T. Prior, J. A. Westman, J. Panescu, D. Fix, J. Lockman, J. LaJeunesse, I. Comeras, and A. de la Chapelle. 2008. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 26(35):5783–5788.

Higashi, M. K., D. L. Veenstra, L. M. Kondo, A. K. Wittkowsky, S. L. Srinouanprachanh, F. M. Farin, and A. E. Rettie. 2002. Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy. JAMA 287(13):1690–1698.

Hughes, D. A. and M. Pirmohamed. 2007. Warfarin pharmacogenetics: Economic considerations. Pharmacoeconomics 25(11):899–902.

Suggested Citation:"References." Institute of Medicine. 2010. The Value of Genetic and Genomic Technologies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12947.
×

IWPC (International Warfarin Pharmacogenetics Consortium). 2009. Estimation of the warfarin dose with clinical and pharmacogenetic data. N Engl J Med 360(8):753–764.

Kangelaris, K. N., S. Bent, R. L. Nussbaum, D. A. Garcia, and J. A. Tice. 2009. Genetic testing before anticoagulation? A systematic review of pharmacogenetic dosing of warfarin. J Gen Intern Med 24(5):656–664.

Limdi, N. A., G. McGwin, J. A. Goldstein, T. M. Beasley, D. K. Arnett, B. K. Adler, M. F. Baird, and R. T Acton. 2008. Influence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin. Clin Pharmacol Ther 83(2):312–321.

Meckley, L. M., J. M. Gudgeon, J. L. Anderson, M. S. Williams, and D. L. Veenstra. 2010. A policy model to evaluate the benefits, risks and costs of warfarin pharmacogenomic testing. Pharmacoeconomics 28(1):61–74.

Mvundura, M., S. D. Grosse, H. Hampel, and G. E. Palomaki. 2010. The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer. Genet Med 12(2):93–104.

Patrick, A. R., J. Avorn, and N. K. Choudhry. 2009. Cost-effectiveness of genotype-guided warfarin dosing for patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes 2(5):429–436.

Rieder M. J., A. P. Reiner, B. F. Gage, D. A. Nickerson, C. S. Eby, H. L. McLeod, D. K. Blough, K. E. Thummel, D. L. Veenstra, and A. E. Rettie. 2005. Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J Med 352(22):2285–2293.

USPSTF (U.S. Preventive Services Task Force). 1996. Guide to Clinical Preventive Services, 2nd Edition. Available at www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=hscps2ed1996 (accessed May 18, 2010).

Veenstra, D. L. 2007. The cost-effectiveness of warfarin pharmacogenomics. J Thromb Haemost 5(9):1974–1975.

Suggested Citation:"References." Institute of Medicine. 2010. The Value of Genetic and Genomic Technologies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12947.
×
Page 55
Suggested Citation:"References." Institute of Medicine. 2010. The Value of Genetic and Genomic Technologies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12947.
×
Page 56
Next: Appendix A: Workshop Agenda »
The Value of Genetic and Genomic Technologies: Workshop Summary Get This Book
×
Buy Paperback | $40.00 Buy Ebook | $32.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Knowing one's genetic disposition to a variety of diseases, including common chronic diseases, can benefit both the individual and society at large. The IOM's Roundtable on Translating Genomic-Based Research for Health held a workshop on March 22, 2010, to bring together diverse perspectives on the value of genetic testing, and to discuss its use in clinical practice.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!